Gibco KnockOut Serum Replacement (SR) is a defined, FBS-free formulation designed to replace FBS in feeder-dependent ESC and iPSC cultures. It has been cited in more than 2,000 publications on various PSC-related applications. Offering documentation required for regulatory review, KnockOut SR helps to reduce the burden of qualifying reagents when transitioning from research applications to clinical applications.
Taking your work to the clinic? Be sure to check out CTS KnockOut SR XenoFree Medium
Figure 1. Undifferentiated ESC growth. Murine D3 ESCs were cultured at low density in DMEM or KnockOut DMEM supplemented with ESC-Qualified FBS or KnockOut SR and traditional supplements. No LIF (leukocyte inhibitory factor) was used. After 7 days, colonies were fixed and stained for alkaline phosphatase, a marker for undifferentiated ESC. Undifferentiated colonies were scored based on morphology and staining characteristics.
Figure 2. Phase contrast image of iPSCs grown in KnockOut SR. iPSC colonies were grown in 20% KnockOut SR, DMEM/F-12 with GlutaMAX supplement, 4 ng/mL Gibco bFGF, and 100 µM 2-mercaptoethanol on mitotically inactivated mouse embryonic fibroblasts. iPSC were passaged with the StemPro EZPassage Disposable Stem Cell Passaging Tool.
| Supplement | Basal medium | Recommended reagent |
|---|---|---|
| KnockOut Serum Replacement |
DMEM/F-12 or KnockOut DMEM |
bFGF or LIF |
For Research Use Only. Not for use in diagnostic procedures.
